High Claudin 18.2 Expression Predicts Favorable Outcomes in Pancreatic Ductal Adenocarcinoma After Curative Resection
High CLDN18.2 expression is associated with favorable clinicopathologic characteristics and improved survival outcomes in PDAC, especially among patients receiving adjuvant chemotherapy, suggesting its potential as a therapeutic and prognostic marker.
Authors
- Seungyun Jee (ORCID: https://orcid.org/0000-0003-3895-817X)
- Hwangkyu Son
- Youn-Lee Oh
- Kihyuk Song
- Woon Yong Jung (ORCID: https://orcid.org/0000-0003-4786-2823)
- Hosub Park
- Jae Kyung Myung (ORCID: https://orcid.org/0000-0001-9612-5323)
- Seongsik Bang (ORCID: https://orcid.org/0000-0002-6872-5986)
- Yeseul Kim (ORCID: https://orcid.org/0000-0001-8273-884X)
- Hyebin Cha
- Hyunsung Kim (ORCID: https://orcid.org/0000-0002-8935-7414)
- Yun Kyung Jung (ORCID: https://orcid.org/0000-0002-5193-5418)
- Seung‐Sam Paik
- Eden Demere Amare
Institutions
- Korea University (KR)
- Kangbuk Samsung Hospital (KR)
- Hanyang University Guri Hospital (KR)
- Hanyang University (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-09-26
- DOI
- https://doi.org/10.21873/anticanres.17802
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00